Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):615-9. doi: 10.1097/QAI.0b013e3181f4b752.

Abstract

Background: The effects of immunologic and virologic factors on acute myocardial infarction (AMI) rates in patients with HIV are unclear.

Methods: HIV-infected patients in a US healthcare system were assessed for AMI.

Results: Of 6517 patients with HIV, 273 (4.2%) had an AMI. In a model adjusting for cardiovascular risk factors, antiretroviral medications, and HIV parameters, CD4 count less than 200/mm (odds ratio, 1.74; 95% confidence interval, 1.07 to 2.81; P = 0.02) predicted AMI. Increased HIV viral load was associated with AMI accounting for cardiovascular disease risk factors and antiretroviral medications but was not significant when CD4 count was considered.

Conclusions: Immunologic control appears to be the most important HIV-related factor associated with AMI.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / virology
  • Cohort Studies
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / immunology*
  • Myocardial Infarction / virology*
  • Risk Factors
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-HIV Agents